INDIANAPOLIS--(BUSINESS WIRE)--Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Medi-Span® customers still have time to add previously released files to map Medi-Span proprietary vocabularies to ICD-10, helping to meet the Department of Human and Health Services (HHS) compliance requirements by the October 2014 deadline.
Nearly one year ago, Medi-Span launched ICD-10 mapping files for its customers to map Medi-Span proprietary vocabularies to ICD-10, helping customers to meet HHS compliance requirements before the previously-set deadline. Several Medi-Span clinical content sets utilize proprietary vocabularies to identify diseases, conditions and procedures. These include Drug Disease Monitoring System™, Medical Conditions Master Database™, The Medi-Span Solution® or Middleware COM, Drug Information Bridge™, and Medi-Span® Clinical. Medi-Span continues to support its customers with the flexibility to either continue with existing Medi-Span solutions or to implement more current and advanced Medi-Span offerings to meet the ICD-10 requirements. Available in flat file and API solutions, these files help enable healthcare systems to translate to and from codes in the patient record, supporting interoperability. The data includes:
- ICD-10-CM and ICD-10-PCS codes, both formatted and unformatted
- A brief description for each code to assist developers with validating their functionality
- Zero, one, or many mappings to Medi-Span Medical Condition Codes or Disease Codes
“Beginning in the fall of 2014, everyone covered under HIPAA will be impacted by ICD-10 implementation,” stated David Del Toro, Vice President & General Manager, Clinical Drug Information, Wolters Kluwer Health, Clinical Solutions. “We are pleased to continue to support Medi-Span customers with timely solutions to help them comply with HHS requirements by the deadline.”
About Medi-Span
Medi-Span® is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer authoritative drug databases in a variety of formats, including clinical decision support and disease suite modules, application programming interfaces and stand-alone software applications. In conjunction with superior implementation and experienced customer support, the Medi-Span product line is the perfect choice for those needing accurate, trusted, drug data that easily integrates into existing software applications.
Medi-Span is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).
